CLINICAL_TRIALS
trial_result
· 2020-03-18
Clinical Trial Update: Autologous Bronchial Basal Cells Transplantation for Treatment of Bronchiectasis [Phase 1, Phase 2]
Summary
A combined Phase 1/Phase 2 clinical trial investigating autologous bronchial basal cell transplantation for bronchiectasis; current status is unknown.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regend Therapeutics | Conditions: Bronchiectasis | Phase 1, Phase 2 | Status: UNKNOWN